A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.
Mice protected by the unconventional vaccine survived exposure to lethal doses of seven of nine widely divergent influenza viruses. Those that received higher doses of the vaccine didn’t even get sick.
In contrast, mice that received traditional flu shots or nasal sprays all sickened and died when exposed to the same viruses. The deadly pathogens were able to evade the immune responses triggered by the traditional vaccines.
While it is too soon to say the approach could be successfully used in humans, it appears to be a promising avenue toward a universal flu shot, according to lead researcher Eric Weaver, an assistant professor in the School of Biological Sciences at the University of Nebraska-Lincoln.
Weaver said the study is the first to report on whether a universal flu shot could be created by using a combination of multiple genes shared at the ancestral level by flu strains circulating today.
“The ultimate goal is to be able to vaccinate once and provide lifelong protection,” Weaver said.
The Centers for Disease Control and Prevention estimates that 40 million Americans contracted influenza during the 2015-16 flu season and 970,000 people were hospitalized for the ailment. The agency estimated that vaccinations prevented about 1.9 million illnesses and 67,000 hospitalizations.
“To put this in other terms, our current influenza vaccine programs and technologies reduce influenza infections and hospitalizations by 4.75 percent and 6.9 percent, respectively,” Weaver said. “There is no doubt that there is a need for more effective vaccine technologies.”
Yet because the influenza virus mutates rapidly and because people, animals and birds often carry the virus without displaying symptoms, it’s been difficult to develop a vaccine with long-term effectiveness. The conventional influenza vaccine platform uses weakened or dead versions of the influenza virus to stimulate immunity against hemagglutinin (HA), a spike-shaped protein that extends from the surface of the virus and attacks cells.
According to a 2013 Clinical Microbiology Reviews article, the challenges of the conventional approach include predicting which flu strain will circulate in coming years; manufacturing and delivering safe, timely and adequate supplies; and poor responsiveness among the elderly, who often are the most vulnerable to influenza infection.
Conventional vaccines have been shown to be less than 60 percent effective when they’re successfully matched to the currently circulating strain. They’re far less effective when mismatched.
“An ideal influenza vaccine would be inexpensive, provide long-lasting immunity, require few immunizations and would work against all variants of the virus,” Weaver said.
Some experts say it could take until 2020 or 2025 before a universal flu vaccine is available.
Pursuit of a universal influenza vaccine has been difficult. Scientists are trying various approaches to better match vaccines to multiple viral strains. Other strategies include developing vaccines aimed at the virus’s protein coat, other proteins that have been found to be identical in multiple flu strains, or the stalk of the hemagglutinin protein rather than its head.
These approaches have shown promising results. However, Weaver said his study is the first to report the use of multiple centralized HA genes, identified using protein sequence analysis programs, to provide the greatest level of cross-protective immunity possible.
In the article published Nov. 2 in Scientific Reports, Weaver and his colleagues Amy Lingel and Brianna L. Bullard detail an approach they say is “scalable and translatable to humans and may provide the foundation for complete and long-lasting anti-influenza immunity.”
The idea arose from past research led by Dr. Bette Korber at Los Alamos National Laboratories to discover the ancestral genes for the Human Immunodeficiency Virus and to pinpoint when that virus jumped from monkeys to man. Weaver was involved with that effort while a post-doctoral researcher at Duke University School of Medicine. He and his colleagues decided to try a similar concept with the influenza virus, synthesizing genes that are central to influenza’s phylogenetic tree.
Instead of using weakened or deadened flu virus, his experiments at the Nebraska Center for Virology have used replication-defective Adenoviruses – which cause the common cold – that have been altered to carry what he calls consensus genes for H1, H2, H3 and H5 influenza strains. The vaccine is no longer capable of causing cold symptoms, but is still able to safely deliver the influenza vaccine genes.
“Our idea is that these centralized antigens can set up a foundation of immunity against influenza,” he said. “Because they are centralized and represent all the strains equally, they could provide a basis for immunity against all evolved strains.”
The Latest on: Flu vaccine
- Influenza a virus-triggered autophagy decreases the pluripotency of human-induced pluripotent stem cells on April 18, 2019 at 6:17 am
Maternal influenza infection during pregnancy was reported multiple times as the possible cause of many defects and congenital anomalies. Apart from several cases of influenza-related miscarriage ... […]
- Structures and functions linked to genome-wide adaptation of human influenza A viruses on April 18, 2019 at 2:15 am
Human influenza A viruses elicit short-term respiratory infections with considerable mortality and morbidity. While H3N2 viruses circulate for more than 50 years, the recent introduction of pH1N1 ... […]
- Grant could bring lifetime flu vaccine on April 17, 2019 at 5:41 pm
Since 1984, a non-profit organization called TED, short for Technology, Entertainment and Design has helped spread groundbreaking ideas around the globe. A subsidiary of TED donated a lot of money to ... […]
- Five more people die from influenza in San Diego this season on April 17, 2019 at 3:42 pm
SAN DIEGO (KGTV) — Five more people died from the flu in San Diego last week. The new deaths, ranging in people aged from 47- to 77-years-old, all had underlying health conditions, according to the ... […]
- UW researchers developing permanent flu vaccine score $45M donation on April 17, 2019 at 12:49 pm
The donation comes from The Audacious Project, an organization that looks to fund projects that can effect positive change on a global scale. UW’s Institute for Protein Design certainly seems to ... […]
- $12 million grant renewal for flu vaccine research on April 17, 2019 at 10:18 am
The National Institutes of Health has awarded the Stanford Institute for Immunity, Transplantation and Infection a five-year, $12 million renewal of a grant for the study of how people respond to ... […]
- Swine Influenza Vaccines 2019 Global Trends, Market Size, Share, Status, SWOT Analysis and Forecast to 2025 on April 17, 2019 at 12:42 am
The global Swine Influenza Vaccines market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to ... […]
- Global Swine Influenza Vaccines Market Prospective Growth, Opportunities, Top Key Players and Forecast to 2025 on April 17, 2019 at 12:35 am
Apr 17, 2019 (Heraldkeeper via COMTEX) -- WiseGuyRerports.com Presents "Global Swine Influenza Vaccines Market Insights, Forecast to 2025" New Document to its Studies Database The global Swine ... […]
- UW institute developing lifetime flu vaccine gets $45 million award on April 16, 2019 at 5:13 pm
A universal flu vaccine that immunizes someone for a lifetime. Smart proteins that can identify cancerous cells. Nanomaterial proteins that self-assemble and could be used for solar energy. These are ... […]
- First-In-Human Trial Begins On Universal Flu Vaccine, Older Adults Still Encouraged To Vaccinate on April 16, 2019 at 7:20 am
As researchers at the National Institutes of Health (NIH) begin clinical trials on a “universal” flu vaccine this month, older adults are reminded that immunizations aren’t just for children anymore. ... […]
via Google News and Bing News